Dr. Jennifer R. Diamond, MD

Dr. Diamond practices at UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth.

Dr. Diamond's NPI, 1912053513, was assigned on January 26, 2007. Dr. Diamond holds Colorado license 45355.

Dr. Diamond's primary practice is UCHealth University of Colorado Hospital, at 12605 E 16th Ave, Aurora, CO 80045 in Adams County. The practice phone is (720) 848-0000.

Dr. Diamond's primary practice is UCHealth University of Colorado Hospital in Aurora, Colorado, part of UCHealth. Dr. Diamond is also affiliated with UCHealth Highlands Ranch Hospital. The medical group on file is University of Colorado Medicine (CU Medicine).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diamond practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Diamond's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Diamond is licensed in Colorado.

CMS data shows 195 Medicare services from Dr. Diamond across 3 procedure codes in 2024, all of them office visits, for 72 Medicare patients. Medicare paid $21,052 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 72 Medicare patients who saw Dr. Diamond in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have cancer, and 65% have high blood pressure. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diamond's median patient age at 64, with 94% women.

In 2024, Dr. Diamond wrote 466 Medicare Part D claims for 84 patients. 73% of them were for generic drugs. CMS names the drug for 383 of them, across 13 drugs with 11 or more claims each, at $1,153,389 in total drug cost. In 2023, CMS named 238 claims across 6 drugs.

Dr. Diamond accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Diamond as offering telehealth.

Dmand AI links 68 papers to Dr. Diamond, published from 2010 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Breast Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Diamond has published most often in Clin Cancer Res. Dr. Diamond's most frequent co-authors are Peter Kabos, MD, Virginia F. Borges, MD and Antonio Jimeno, MD.

Dmand AI links Dr. Diamond to 12 clinical trials, 4 of them phase 1 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Triple Negative Breast Neoplasms. National Cancer Institute (NCI) sponsors the most, 2. Open Payments lists research payments to Dr. Diamond that name 2 trials.

CMS Open Payments shows 36 general payments to Dr. Diamond from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 55% of the total. Gilead Sciences, Inc. paid the most, $6,721. It also lists 2 research payments totaling $970 in 2016, naming 2 clinical trials.